---
document_datetime: 2023-09-21 19:18:39
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/angiox-epar-all-authorised-presentations_en.pdf
document_name: angiox-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.4852825
conversion_datetime: 2025-12-26 20:32:33.401139
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
EU number

EU/1/04/289/001

Strength

250 mg

Pharmaceutical Form

Powder for concentrate for solution for injection or infusion

Route of administration

Intravenous use

Packaging

Vial (glass)

Package size

10 vials

Invented name Angiox Medicinal product no longer authorised